21 – 30 of 43
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine
(
- Contribution to journal › Article
- 2007
-
Mark
In vivo and in vitro intragenomic rearrangement of TT viruses
(
- Contribution to journal › Article
-
Mark
Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring
(
- Contribution to journal › Article
-
Mark
Nordic biological specimen banks as basis for studies of cancer causes and control - more than 2 million sample donors, 25 million person years and 100 000 prospective cancers
(
- Contribution to journal › Article
-
Mark
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine
(
- Contribution to journal › Article
-
Mark
Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection
(
- Contribution to journal › Article
-
Mark
Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions
(
- Contribution to journal › Article
- 2006
-
Mark
Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries
(
- Contribution to journal › Article
-
Mark
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
(
- Contribution to journal › Article
- 2005
-
Mark
Abstract I: Prevalence and stability of human serum antibodies to simian virus 40 VP1 virus-like particles
(
- Contribution to journal › Article